Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Multiple Myeloma × dostarlimab × Clear all

Phase

Phase 2 1 Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Endometrial Neoplasms 7 Uterine Cervical Neoplasms 5 Neoplasms 5 Ovarian Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Pancreatic Neoplasms 3 Neoplasm Metastasis 3 Head and Neck Neoplasms 3 Colonic Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Rectal Neoplasms 2 Carcinoma, Neuroendocrine 2 Breast Neoplasms 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Turcot syndrome 1 Triple Negative Breast Neoplasms 1 Small Cell Lung Carcinoma 1 Sarcoma, Clear Cell 1 Sarcoma 1 Penile Neoplasms 1 Pathologic Complete Response 1 Multiple Myeloma 1 Mesothelioma, Malignant 1 Melanoma 1 MMRd/MSI-H Stage II-III Endometrial Cancer 1 MMR-D/MSI-H Colorectal Cancers 1 Lung Neoplasms 1 Locally Advanced Rectal Cancer (LARC) 1 Hemangiosarcoma 1

Interventions

Dexamethasone 294 Bortezomib 160 Lenalidomide 155 Cyclophosphamide 143 Melphalan 107 Calcium Dobesilate 93 daratumumab 82 pomalidomide 58 carfilzomib 58 fludarabine phosphate 53 Peripheral Blood Stem Cell Transplantation 53 Thalidomide 46 Filgrastim 46 Mycophenolic Acid 42 Busulfan 42 ixazomib 39 fludarabine 36 Granulocyte Colony-Stimulating Factor 35 Whole-Body Irradiation 34 Tacrolimus 34 dexamethasone acetate 29 Etoposide 28 Cyclosporine 28 Antilymphocyte Serum 27 isatuximab 25 dexamethasone 21-phosphate 24 auricularum 23 plerixafor 21 Radiotherapy 21 elotuzumab 20

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04126200 2025-11-06

DREAMM5

GlaxoSmithKline

Phase 2 Active not recruiting

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡